News

Brief news reports on Tuberculosis

25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward

A personal view, published in The Lancet Infectious Diseases, presented the achievements, challenges, and way forward for the oldest and largest global antimicrobial resistance surveillance system. Hosted by the World Health Organization since 1994, the Global Project on Anti-Tuberculosis Drug Resistance Surveillance has served as a platform for the evaluation of the trends in TB drug resistance for over 25 years at country, regional, and global levels.

Read More →

South Africa: Shorter, simpler DR-TB regimen expected later this year

Work is underway in South Africa to amend the country’s national guidelines for drug-resistant TB to provide a shorter, six-month, all-oral regimen as a new standard of care treatment.

Read More →

Being heard on all-oral therapy for resistant TB

A study, published in The Lancet Infectious Diseases, compared outcomes up to 24 months after treatment initiation for patients with rifampicin-resistant TB in South Africa treated with a short, all-oral bedaquiline-containing regimen, or a short, injectable-containing regimen.

Read More →

Report from the scoping consultation on severe bacterial infections among people with advanced HIV disease

The World Health Organization (WHO) convened a scoping consultation on severe bacterial infections (SBIs) in advanced HIV disease (AHD), consulting with academics, program managers and civil society representatives.

Read More →

Call for new membership: Communities Delegation to UNITAID Board

The Communities Delegation to the UNITAID Board represents people living with and affected by HIV, TB and malaria and those co-infected with HIV and HCV, at the UNITAID Board and Committee level. The Communities Delegation is currently recruiting new members for the period 2022-2025. Interested individuals are invited to express their interest by 15 July 2022.

Read More →

Genetic mutations enable efficient evolution of TB-causing bacteria

Jun 21, 2022: Researchers have identified how the bacterium that causes tuberculosis (TB) can evolve rapidly in response to new environments, says a study published today in eLife.

Read More →

Global TB Caucus regional forum: TB and migration

On 27 June 2022, the Global TB Caucus will host an online regional (Europe and Central Asia) forum: TB and migration. The forum will discuss the effects migration has on TB, in light of the recent events in Ukraine that have caused a spike in migration with an estimated five million people internally or externally displaced.

Read More →

Analysis: People-centered, rights-based TB legislation in Eastern Europe and Central Asia

The Global TB Caucus releases an analysis examining the region’s laws on public health, health systems, labor, TB, and other infectious diseases.

Read More →

Global TB Caucus: TB video series

The Global TB Caucus released a three-part video series: shorter-form primers that can easily inform people on key topics in the discussion surrounding TB.

Read More →

The intersection of SARS-CoV-2 with TB: It's complicated

A new animal study found mice infected with Mycobacterium tuberculosis and SARS-CoV-2 had an interesting synergism, according to a poster presented at ASM Microbe 2022 (abstract 3696), in Washington, D.C.

Read More →

Page 1 of 804 · Total posts: 10

1 2 Last→